Press release
Glaucoma Therapeutics Market Share, Size & Trend | Industry Analysis Report 2026
Rising prevalence of glaucoma and other visual impairments have led to an increase in the demand for therapeutic drugs to treat these conditions. Around one-tenth of the elderly population suffers from glaucoma, which is expected to increase with each passing year. Consequently, the demand for better therapy options for the treatment of glaucoma is expected to boost demand for therapeutics.Click HERE to Get Synopsis of the Report- https://www.factmr.com/report/4775/glaucoma-therapeutics-market
On the back of these factors, the global glaucoma therapeutics market shall witness a gradual growth, at a CAGR of 2.9% during the forecast period (2020-2026). Other generic drivers, such as a greater geriatric population pool, a rise in the diabetic population and higher healthcare spending and infrastructure shall boost market growth.
Key Takeaways of Global Glaucoma Therapeutics Market Study
Prostaglandins are anticipated to account for the maximum market share of the glaucoma therapeutics market. This is attributed to its increased adoption in first line glaucoma treatment. The drug reduces intraocular pressure (IOP) by increasing uveoscleral flow. Projections indicate a market share of more than two-fifth of the total glaucoma therapeutics market.
Combination medicines are becoming more prevalent for glaucoma treatment. Greater effectiveness of treatment over individual medications is a key growth driver for this segment. For example, the Rhopressa drug class, a combination formula developed by Aerie Pharmaceuticals, has been approved for usage in commercial glaucoma treatment. Projected CAGR for combination medicines is pegged at 4.7% during the forecast period.
Hospitals shall account for the majority of the share of glaucoma therapeutics between 2020 and 2026. Increasing number of patients coupled with the ability to provide optimum healthcare services are major growth drivers.
North America is set to remain a lucrative market for glaucoma therapeutics. Increased focus on research and development of therapeutic drugs and approvals of certain drug categories like Rhopressa are expected to leverage the region’s market share. Asia-Pacific is following close behind, with a projected CAGR of 3.2% during the forecast period. Introduction of new drugs like Travopost and Timolol are expected to invigorate Asia-Pacific’s market share.
For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=4775
COVID-19’s Impact:
Leading players are concentrating on safeguarding the supply chain of their products in response to the COVID-19 pandemic. Alcon, for instance, has initiated its Global Crisis Management program to ensure continuity of business operations. Manufacturing sites are functional to ensure production of essential glaucoma drugs. Bausch Health, another player, has directed its funds towards developing VIRAZOLE, a potential drug which may help fight the COVID-19 pandemic.
It is working in co-operation with key health authorities for the same. Aerie Pharmaceuticals reported a decline in the pace of volumes for its Rhopressa and Rocklatan drugs during the first quarter of 2020 due to COVID-19. Fortunately, no supply chain disruptions have been experienced. The company has adequate inventory to ensure a consistent supply for at least six months.
“The glaucoma therapeutics market shows a positive growth trend. Its market is expected to be invigorated by continuous research and product development, especially in combination drugs. Leading market players have accordingly developed formulae which can assist in faster recovery of glaucoma patients,” concludes a Fact.MR analyst.
Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4775
Combination Drugs; a Growth Lever for Market Players
The global glaucoma therapeutics market consists of the following market players: Allergan plc, Merck & Co., Inc., Novartis AG, Pfizer Inc., Santen Pharmaceuticals Co. Ltd., Valeant Pharmaceuticals, Inc. and Aerie Pharmaceuticals, Inc. Novartis AG’s Alcon division focuses on development of eye care products, such as Travatan, Simbrinza and Azarga. Allergan Plc., occupies the second position in the market, and include top selling brands like Lumigan, Alphagan, Ganfort and Combigan. More recently, the company also received an approval from the FDA to launch its DURYSTATM Biodegradable Sustained-Release Implant. This device is designed to reduce intraocular pressure in open-angle glaucoma or ocular hypertension patients.
Looking for more information?
The research study on the glaucoma therapeutics market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global glaucoma therapeutics market over 2020-2026. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of Drug Class (Prostaglandins, Beta Blockers, Alpha Agonists, Carbonic Anhydrase Inhibitors, Combination Medications and Cholinergics and End-user (Hospitals, Ophthalmic Clinics and Ambulatory Surgical Centers) across five major regions.
Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4775/S
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email : sales@factmr.com
Website : https://www.factmr.com
Research Insight: https://www.factmr.com/report/4775/glaucoma-therapeutics-market
Content Source: https://www.factmr.com/media-release/1540/global-glaucoma-therapeutics-market
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.
We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.
Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glaucoma Therapeutics Market Share, Size & Trend | Industry Analysis Report 2026 here
News-ID: 2277314 • Views: …
More Releases from Fact.MR
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world…
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a…
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable…
Fibrin Sealants Market is Anticipated to Reach USD 1.92 Billion by 2033 | Fact.M …
The global fibrin sealants market is valued at USD 976.5 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 7%, reaching USD 1.92 billion by 2033. This growth is driven by the increasing prevalence of surgical procedures requiring effective hemostasis and tissue sealing, particularly in cardiovascular, orthopedic, and general surgeries. Fibrin sealants, derived from human plasma proteins, mimic the body's natural clotting process,…
More Releases for Pharmaceuticals
Cystic fibrosis Market: Epidemiology, Therapies, Companies, DelveInsight | Veron …
Cystic fibrosis therapies, such as TRIKAFTA, SYMDEKO, KALYDECO, VX-121/TEZ/ VX-561, Ensifentrine, and others, are expected to boost the Cystic fibrosis Market in the upcoming years.
DelveInsight has launched a new report on "Cystic fibrosis - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Cystic fibrosis, historical and forecasted epidemiology as well as the Cystic fibrosis market trends in the United States, EU5 (Germany, Spain, Italy, France,…
Gastritis Drugs Market Size Report 2032 | Regeneron Pharmaceuticals, Sanofi, Han …
DelveInsight's "Gastritis Market Insights, Epidemiology, and Market Forecast -2032" report delivers an in-depth understanding of the Gastritis, historical and forecasted epidemiology as well as the Gastritis market trends in the United States, EU4 (Germany, Spain, Italy, France) and the United Kingdom, and Japan.
Key Takeaways from the Gastritis Market Research Report
• The increase in Gastritis Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging…
Generic Pharmaceuticals Market Set for More Growth| Hikma Pharmaceuticals, Emcur …
Advance Market Analytics published a new research publication on "Generic Pharmaceuticals Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Generic Pharmaceuticals market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample Copy of…
Global Halal Pharmaceuticals Market 2019 - CCM Pharmaceuticals, Pharmaniaga, Ros …
This new report by Eon Market Research, titled “Global Halal Pharmaceuticals Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Halal Pharmaceuticals industry at a global as well as regional and country level. Key facts analyzed in this report include the Halal Pharmaceuticals market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study…
Topical Antibiotic Pharmaceuticals Market 2016-2026 | Teva Pharmaceuticals, Perr …
Topical antibiotics are applied to a certain area of the skin to kill infections. Application of topical antibiotics has a number of advantages upon comparison of systemic delivery in the treatment of skin infections. Skin and soft tissue infections (SSTIs) involve microbial invasion of the skin and underlying soft tissues infections are one of the most commonly occurring conditions amongst people. Most of these infections are minor and chronic in…
Lipid Disorder Treatment Market to 2017 - 2026: Teva Pharmaceuticals, Mylan Phar …
Researchmoz added Most up-to-date research on "Lipid Disorder Treatment Market - Global Industry Analysis, Share, Size, Growth, Trends and Forecast 2017 - 2026" to its huge collection of research reports
Extensive research report on global lipid disorders treatment market skilfully crafted by Transparency Market Research depicts the current as well as future scenario of various drugs used to treat lipid disorders. The research study includes analysis on key developments that are…
